Green Cross Medical Science (XKRX:142280) ROCE % : 22.46% (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Green Cross Medical Science ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Green Cross Medical Science's annualized ROCE % for the quarter that ended in Dec. 2024 was 22.46%.

Green Cross Medical Science ROCE % Historical Data

The historical data trend for Green Cross Medical Science's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Cross Medical Science ROCE % Chart

Green Cross Medical Science Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

12.41

-35.20

-0.15

10.25

13.12

Green Cross Medical Science Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-2.65	19.35	5.51	5.29	22.46

Green Cross Medical Science ROCE % Calculation

Green Cross Medical Science's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	6220.179	/	( ( (90529.343 - 46527.717)	+	(87974.527 - 37122.889) )	/ 2 )
	=	6220.179	/	( (44001.626	+	50851.638)	/ 2 )
	=	6220.179	/	47426.632
	=	13.12 %

Green Cross Medical Science's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	11194.76	/	( ( (89091.726 - 40269.168)	+	(87974.527 - 37122.889) )	/ 2 )
	=	11194.76	/	( ( 48822.558	+	50851.638 )	/ 2 )
	=	11194.76	/	49837.098
	=	22.46 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Green Cross Medical Science (XKRX:142280) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Green Cross Medical Science ROCE % Related Terms

Thank you for viewing the detailed overview of Green Cross Medical Science's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Green Cross Medical Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Cross Medical Science Corp (XKRX:142280) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

107, Ihyeon-ro 30beon-gil, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 16924

Website

http://www.greencross.com

Green Cross Medical Science Corp is a total medical device company. It is engaged in the blood glucose business, kidney hemodialysis business, and blood bag business with the application of its know-how in in-vitro diagnostics. The product portfolio offered by the organization includes diagnostic reagents, diagnostic instruments, blood bag, home medical devices, blood dialysis products and HbA1c/BGMS.

Green Cross Medical Science Headlines

No Headlines